title: β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.
abstract: The β-adrenoceptor agonists BRL37344 and clenbuterol have opposite effects on glucose uptake in mouse soleus muscle, even though the β2-adrenoceptor mediates both effects. Different agonists may direct the soleus muscle β2-adrenoceptor to different signalling mechanisms. Soleus muscles were incubated with 2-deoxy[1-(14)C]-glucose, β-adrenoceptor agonists, other modulators of cyclic AMP, and inhibitors of intracellular signalling. The adenylyl cyclase activator forskolin (1 μM), the phosphodiesterase inhibitor rolipram (10 μM) and BRL37344 (10, but not 100 or 1,000, nM) increased, whereas clenbuterol (100 nM) decreased, glucose uptake. Forskolin increased, whereas clenbuterol decreased, muscle cyclic AMP content. BRL37344 (10 nM) did not increase cyclic AMP. Nevertheless, protein kinase A (PKA) inhibitors prevented the stimulatory effect of BRL37344. Nanomolar but not micromolar concentrations of adrenaline stimulated glucose uptake. After preincubation of muscles with pertussis toxin (100 ng/ml), 100 nM clenbuterol, 0.1-10 μM adrenaline and 100 nM BRL37344 stimulated glucose uptake. Clenbuterol increased the proportion of phosphorylated to total β2-adrenoceptor. Inhibitors of phosphatidylinositol 3-kinase (PI3K) and the stress-activated mitogen-activated protein kinase (MAPK), but not of the classical MAPK pathway, prevented stimulation of glucose uptake by BRL37344. Elevation of the cyclic AMP content of soleus muscle stimulates glucose uptake. Clenbuterol, and high concentrations of adrenaline and BRL37344 direct the β2-adrenoceptor partly to Gαi, possibly mediated by β2-adrenoceptor phosphorylation. The stimulatory effect of 10 nM BRL37344 requires the activity of PKA, PI3K and p38 MAPK, consistent with BRL37344 directing the β2-adrenoceptor to Gαs. Ligand-directed signalling may explain why β2-adrenoceptor agonists have differing effects on glucose uptake in soleus muscle.
authors.affiliation: Department of Molecular Medicine, School of Medical Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Ngala
authors.forename: Jacqueline F
authors.initials: JF
authors.lastname: O'Dowd
authors.forename: Claire J
authors.initials: CJ
authors.lastname: Stocker
authors.forename: Michael A
authors.initials: MA
authors.lastname: Cawthorne
authors.forename: Jonathan R S
authors.initials: JR
authors.lastname: Arch
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000494:pharmacology*; D000818:Animals; D002976:Clenbuterol / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D008024:Ligands; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D004983:Ethanolamines; D008024:Ligands; C057368:BRL 37344; D000242:Cyclic AMP; D019869:Phosphatidylinositol 3-Kinases; D017868:Cyclic AMP-Dependent Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D005947:Glucose; D002976:Clenbuterol; D004837:Epinephrine
references.citation: Br J Pharmacol. 2006 Feb;147(4):446-54
references.pmid: 16415914
references.citation: Clin Exp Pharmacol Physiol. 2008 Dec;35(12):1488-92
references.pmid: 18759853
references.citation: Eur J Pharmacol. 1998 Dec 4;362(2-3):261-6
references.pmid: 9874179
references.citation: Sci China C Life Sci. 2007 Dec;50(6):739-47
references.pmid: 17882384
references.citation: J Biol Chem. 1995 Feb 3;270(5):2107-11
references.pmid: 7836438
references.citation: Biochem Biophys Res Commun. 2002 Dec 20;299(5):693-6
references.pmid: 12470633
references.citation: Circ Res. 2002 Jul 12;91(1):46-53
references.pmid: 12114321
references.citation: Acta Physiol (Oxf). 2009 May;196(1):175-90
references.pmid: 19245659
references.citation: Br J Pharmacol. 2010 Mar;159(5):1022-38
references.pmid: 20132209
references.citation: FEBS Lett. 1996 Mar 11;382(1-2):43-7
references.pmid: 8612761
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1810-8
references.pmid: 17234956
references.citation: Mol Cell Biol. 2009 Feb;29(3):675-86
references.pmid: 19047375
references.citation: Mol Pharmacol. 2007 Nov;72(5):1359-68
references.pmid: 17717109
references.citation: Diabetes. 2002 Mar;51(3):615-23
references.pmid: 11872658
references.citation: Circ Res. 1999 Jan 8-22;84(1):43-52
references.pmid: 9915773
references.citation: Am J Physiol Endocrinol Metab. 2008 May;294(5):E889-97
references.pmid: 18303121
references.citation: Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E123-9
references.pmid: 12791603
references.citation: Eur J Cancer. 2010 Apr;46(6):1111-21
references.pmid: 20129775
references.citation: Am J Physiol. 1998 Sep;275(3):E448-56
references.pmid: 9725811
references.citation: J Biol Chem. 2001 Jun 8;276(23):19800-6
references.pmid: 11279172
references.citation: J Clin Invest. 2001 Oct;108(8):1167-74
references.pmid: 11602624
references.citation: Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H385-93
references.pmid: 17369456
references.citation: Nat Chem Biol. 2011 Aug 21;7(10):692-700
references.pmid: 21857662
references.citation: Diabetes. 1997 Nov;46(11):1691-700
references.pmid: 9356014
references.citation: Br J Pharmacol. 2002 Apr;135(8):1903-14
references.pmid: 11959793
references.citation: J Biol Chem. 1994 Feb 18;269(7):5241-8
references.pmid: 8106507
references.citation: J Physiol. 2009 Jul 1;587(Pt 13):3363-73
references.pmid: 19403598
references.citation: Endocrinology. 2004 Jan;145(1):269-80
references.pmid: 14551227
references.citation: Br J Pharmacol. 1996 Mar;117(6):1355-61
references.pmid: 8882636
references.citation: Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E57-66
references.pmid: 19435854
references.citation: J Appl Physiol (1985). 2002 Oct;93(4):1457-65
references.pmid: 12235047
references.citation: EMBO J. 1996 Oct 1;15(19):5256-67
references.pmid: 8895571
references.citation: Br J Pharmacol. 2007 Jun;151(4):476-82
references.pmid: 17450172
references.citation: Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1917-26
references.pmid: 18775853
references.citation: Mol Pharmacol. 2004 May;65(5):1313-22
references.pmid: 15102960
references.citation: Eur J Pharmacol. 1998 May 1;348(1):53-60
references.pmid: 9650831
references.citation: Mol Pharmacol. 2003 Dec;64(6):1357-69
references.pmid: 14645666
references.citation: J Biol Chem. 2008 Jan 25;283(4):1799-807
references.pmid: 18056263
references.citation: Biochem Biophys Res Commun. 1995 Mar 28;208(3):1147-53
references.pmid: 7702613
references.citation: Trends Pharmacol Sci. 2007 Aug;28(8):374-81
references.pmid: 17629959
references.citation: Med Sci Monit. 2006 Jan;12(1):BR28-35
references.pmid: 16369460
references.citation: Diabetologia. 2007 Jan;50(1):158-67
references.pmid: 17119919
references.citation: Br J Pharmacol. 2009 Dec;158(7):1676-82
references.pmid: 19912225
references.citation: Br J Pharmacol. 2008 Oct;155(3):395-406
references.pmid: 18552870
references.citation: Nitric Oxide. 2006 May;14(3):200-11
references.pmid: 16413212
references.citation: Neuroendocrinology. 2006;84(6):378-85
references.pmid: 17230011
references.citation: J Pharmacol Exp Ther. 2005 Mar;312(3):1064-74
references.pmid: 15574684
references.citation: Nature. 1997 Nov 6;390(6655):88-91
references.pmid: 9363896
references.citation: Endocrinology. 2006 Nov;147(11):5170-7
references.pmid: 16873531
references.citation: Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E335-40
references.pmid: 11440910
references.citation: Diabetes. 2006 Mar;55(3):682-90
references.pmid: 16505231
references.citation: Circ Res. 2004 Dec 10;95(12):1183-90
references.pmid: 15539636
references.citation: Am J Physiol. 1985 May;248(5 Pt 1):C406-9
references.pmid: 3993767
references.citation: Cell Signal. 2007 Sep;19(9):1949-55
references.pmid: 17629454
references.citation: Mol Pharmacol. 2006 Nov;70(5):1575-84
references.pmid: 16901982
references.citation: J Biol Chem. 1986 Jan 25;261(3):989-92
references.pmid: 3511044
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:297-323
references.pmid: 14744248
references.citation: Diabetologia. 2005 Nov;48(11):2386-95
references.pmid: 16160864
references.citation: Trends Pharmacol Sci. 1995 Jul;16(7):232-8
references.pmid: 7667897
references.citation: J Clin Invest. 1998 Oct 1;102(7):1377-84
references.pmid: 9769330
references.citation: Biochem J. 1993 Dec 1;296 ( Pt 2):297-301
references.pmid: 8257416
references.citation: Biochem J. 2000 Oct 1;351(Pt 1):95-105
references.pmid: 10998351
references.citation: Am J Physiol. 1998 Apr;274(4):E692-9
references.pmid: 9575831
references.citation: Br J Pharmacol. 2004 Dec;143(8):1014-22
references.pmid: 15466444
references.citation: J Appl Physiol (1985). 1996 Oct;81(4):1501-9
references.pmid: 8904560
references.citation: J Clin Invest. 1981 Sep;68(3):706-13
references.pmid: 6115864
references.citation: Acta Physiol Scand Suppl. 1987;564:1-80
references.pmid: 2890259
references.citation: Br J Pharmacol. 2012 Mar;165(5):1442-56
references.pmid: 21883150
references.citation: Diabetes Obes Metab. 2003 Sep;5(5):295-301
references.pmid: 12940866
references.citation: Biol Chem Hoppe Seyler. 1996 Jun;377(6):373-84
references.pmid: 8839983
references.citation: Br J Pharmacol. 2006 Nov;149(6):635-46
references.pmid: 17016512
references.citation: J Endocrinol. 1993 Dec;139(3):479-86
references.pmid: 7907647
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10776-81
references.pmid: 12954981
references.citation: Mol Endocrinol. 2002 Feb;16(2):331-41
references.pmid: 11818504
references.citation: Am J Physiol. 1980 Dec;239(6):E461-7
references.pmid: 7446724
references.citation: Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R561-71
references.pmid: 11448861
references.citation: Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1205-11
references.pmid: 16418205
references.citation: Am J Physiol Endocrinol Metab. 2004 May;286(5):E809-17
references.pmid: 14722032
references.citation: Cell Metab. 2006 Jun;3(6):403-16
references.pmid: 16753576
references.citation: Eur J Pharmacol. 2000 Oct 6;406(1):33-40
references.pmid: 11011029
references.citation: Diabetes. 2001 Jan;50(1):12-7
references.pmid: 11147776